首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >Optimized Human Regular U-500 Insulin Treatment Improves beta-Cell Function in Severely Insulin-Resistant Patients with Longstanding Type 2 Diabetes and High Insulin Requirements (vol 21, pg 1344, 2015)

【24h】

Optimized Human Regular U-500 Insulin Treatment Improves beta-Cell Function in Severely Insulin-Resistant Patients with Longstanding Type 2 Diabetes and High Insulin Requirements (vol 21, pg 1344, 2015)

机译：优化的人类常规U-500胰岛素治疗可改善具有长期2型糖尿病和高胰岛素需求的严重胰岛素抵抗患者的β细胞功能（第21卷，第1344页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists》 |2016年第5期|共1页
作者
Mari;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Optimized Human Regular U-500 Insulin Treatment Improves beta-Cell Function in Severely Insulin-Resistant Patients with Longstanding Type 2 Diabetes and High Insulin Requirements (vol 21, pg 1344, 2015) [J] . Mari Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2016,第5期

机译：优化的人类常规U-500胰岛素治疗可改善具有长期2型糖尿病和高胰岛素需求的严重胰岛素抵抗患者的β细胞功能（第21卷，第1344页，2015年）
2. Two Treatment Approaches for Human Regular U-500 Insulin in Patients with Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-to-Target Clinical Trial (vol 21, pg 782, 2015) [J] . Hood Robert C., Arakaki Richard F., Wysham Carol, Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2016,第7期

机译：在使用或不使用口服药物的大剂量U-100胰岛素治疗中未实现充分血糖控制的2型糖尿病患者中人类常规U-500胰岛素的两种治疗方法：一项随机，以滴定为目标的临床试验（第21卷，第782页，2015年）
3. Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial [J] . Samaneh Kabul, Robert C. Hood, Ran Duan, Health and Quality of Life Outcomes . 2016,第1期

机译：患者报告的结果在高剂量U-100胰岛素到人常规U-500胰岛素的过渡，在严重的胰岛素抗性患者2型糖尿病患者中：随机临床试验分析
4. Optimization of Insulin Dosing in Patients with Type 1 Diabetes Mellitus [C] . Stamatina Zavitsanou, Athanasios Mantalaris, Michael C. Georgiadis, European symposium on computer aided process engineering . 2014

机译：1型糖尿病患者胰岛素剂量的优化
5. Incidence of hypoglycemia and associated costs in Type 1and Type 2 diabetes patients treated with insulin analogs vs. human insulin: A retrospective cohort study. [D] . Shah, Hiren P. 2014

机译：使用胰岛素类似物与人胰岛素治疗的1型和2型糖尿病患者的低血糖发生率和相关费用：一项回顾性队列研究。
6. Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial [O] . Samaneh Kabul, Robert C. Hood, Ran Duan, 2016

机译：在严重胰岛素抵抗的2型糖尿病患者中患者报告的从大剂量U-100胰岛素向人常规U-500胰岛素过渡的结果：一项随机临床试验分析
7. Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial [O] . 2016

机译：在严重胰岛素抵抗的2型糖尿病患者中，患者报告的从大剂量U-100胰岛素向人常规U-500胰岛素过渡的结果：一项随机临床试验分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号